CAC
Cowen and Company’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,244,498
| Closed | -$39.9M | – | 234 |
|
|
2024
Q3 | $39.9M | Sell |
3,244,498
-121,246
| -4% | -$1.49M | 1.34% | 14 |
|
|
2024
Q2 | $45.5M | Hold |
3,365,744
| – | – | 1.25% | 13 |
|
|
2024
Q1 | $45.4M | Sell |
3,365,744
-355,915
| -10% | -$4.8M | 1.76% | 8 |
|
|
2023
Q4 | $19.6M | Hold |
3,721,659
| – | – | 1.28% | 22 |
|
|
2023
Q3 | $14.7M | Hold |
3,721,659
| – | – | 1.03% | 25 |
|
|
2023
Q2 | $39.6M | Buy |
3,721,659
+442,517
| +13% | +$4.7M | 3.28% | 7 |
|
|
2023
Q1 | $27.3M | Buy |
3,279,142
+2,531,065
| +338% | +$21.1M | 3.21% | 5 |
|
|
2022
Q4 | $6.9M | Sell |
748,077
-21,092
| -3% | -$195K | 0.72% | 27 |
|
|
2022
Q3 | $9.88M | Sell |
769,169
-740,451
| -49% | -$9.51M | 0.94% | 26 |
|
|
2022
Q2 | $19.9M | Buy |
1,509,620
+89,090
| +6% | +$1.18M | 1.93% | 14 |
|
|
2022
Q1 | $29.9M | Buy |
1,420,530
+1,125,105
| +381% | +$23.7M | 2.88% | 9 |
|
|
2021
Q4 | $6.84M | Buy |
295,425
+259,526
| +723% | +$6M | 0.62% | 31 |
|
|
2021
Q3 | $913K | Buy |
+35,899
| New | +$913K | 0.04% | 139 |
|